TGFA antibody (C-Term)
Quick Overview for TGFA antibody (C-Term) (ABIN967168)
Target
See all TGFA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 73-90, C-Term
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminal of human TGF (73-90 aa), different from the mouse sequence by one amino acid.
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Reconstitution
- 0.2ml of distilled water will yield a concentration of 500µg/ml.
-
Buffer
- Each vial contains 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4
-
Preservative
- Thimerosal (Merthiolate), Sodium azide
-
Storage
- -20 °C
-
-
-
: "In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, Issue 26, pp. 14686-91, (2001) (PubMed).
-
-
- TGFA (Transforming Growth Factor, alpha (TGFA))
-
Alternative Name
- TGFalpha
-
Background
- Transforming growth factor alpha (TGF-) is upregulated in some human cancers. It is produced in macrophages, brain cells, and keratinocytes, and induces epithelial development. It is closely related to EGF, and can also bind to the EGF receptor with similar effects . TGF stimulates neural cell proliferation in the adult injured brain. TGF was cited in the 2001 NIH Stem Cell report to the U.S. Congress as promising evidence for the ability of adult stem cells to restore function in neurodegenerative disorders.
-
Pathways
- NF-kappaB Signaling, RTK Signaling, EGFR Signaling Pathway
Target
-